Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 5, 2021 - Issue 1
Journal homepage
123
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Methotrexate-associated lymphoproliferative disorder with histopathological features of histiocytic necrotizing lymphadenitis

Shuko Kaitoa Department of General Internal Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, JapanCorrespondence[email protected]
,
Masashi Gotoa Department of General Internal Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
,
Mikiko Iguchib Department of Rheumatology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
,
Yoshiaki Okunoc Department of Hematology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
,
Koki Moriyoshid Department of Diagnostic Pathology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
&
Hiroshi Koyamaa Department of General Internal Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Pages 141-144 | Received 17 Jan 2020, Accepted 25 May 2020, Published online: 18 Jun 2020

References

  • Ellman MH, Hurwitz H, Thomas C, et al. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991;18:1741–1743.
  • Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14(6):1943–1949.
  • Georgescu L, Quinn GC, Schwartzman S, et al. Lymphoma in patients with rheumatoid arthritis: Association with the disease state or methotrexate treatment. Semin Arthritis Rheum. 1997;26(6):794–804.
  • Gaulard P, Swerdlow SH, Harris NL, et al. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. Lyon: IARC Press; 2008.
  • Fujimoto Y, Kozima Y, Hamaguchi K. Cervical necrotizing lymphadenitis: a new clinicopathological agent (in Japanese). Naika. 1972;20:920–927.
  • Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytosis (in Japanese). Nippon Ketsueki Gakkai Zasshi. 1972;35:378–380.
  • Romero Guadarrama MB, Guzman-Aguilar OD, Lopez-Ugalde AC, et al. Kikuchi-Fujimoto disease associated to the Epstein-Barr Virus. A type of rare necrotizing lymphadenitis and its differential diagnosis. OJPathology. 2013;03(04):186–192.
  • Nakamura I, Imamura A, Yanagisawa N, et al. Medical study of 69 cases diagnosed as Kikuchi’s disease (in Japanese). Kansenshogaku Zasshi. 2009;83(4):363–368.
  • Dumas G, Prendki V, Haroche J, et al. Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature. Medicine (Baltimore). 2014;93(24):372–382.
  • Eboriadou M, Tragiannidis A, Markou K, et al. Kikuchi-Fujimoto disease associated with extreme leukopenia and thrombocytopenia in an adolescent boy. J Pediatr Hematol Oncol. 2007;29(12):864.
  • Lu HX, Xiao HJ, Wang LL, Liu X, et al. [One case of histiocytic necrotizing lymphadenitis with severe thrombocytopenia]). Zhonghua Nei Ke Za Zhi. 2020;59(4):314–315.
  • Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34(2):322–331.
  • Saito S, Kaneko Y, Yamaoka K, et al. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatology (Oxford). 2017;56(6):940–946.
  • Kondo M, Murakawa Y, Moriyama M, et al. Distinct decrease in peripheral lymphocytes in EBER-positive cases of MTX-LPD. Mod Rheumatol. 2020;Mar 3:1–6. DOI:10.1080/14397595.2020.1733246
  • Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum. 2007;56(5):1433–1439.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.